Implication of PDGF signaling in cigarette smoke-induced pulmonary arterial hypertension in rat

Inhalation Toxicology

Volumn 24, Issue 8, 2012, Pages 468-475

  Xing, Ai Ping ^a   Hu, Xiao Yun ^a   Shi, Yi Wei ^a   Du, Yong Cheng ^a,b  

^a SHANXI MEDICAL UNIVERSITY   (China)

^b SHAANXI PROVINCIAL PEOPLE S HOSPITAL   (China)

Author keywords

Cigarette smoke (CS); Imatinib; PDGF; PDGF receptor; Pulmonary arterial hypertension (PAH)

Indexed keywords

CIGARETTE SMOKE; IMATINIB; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR B; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE HYPERTROPHY; HISTOLOGY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SYSTOLIC BLOOD PRESSURE;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; HYPERTENSION, PULMONARY; HYPERTROPHY, RIGHT VENTRICULAR; INHALATION EXPOSURE; LUNG; MALE; PLATELET-DERIVED GROWTH FACTOR; PULMONARY ARTERY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SMOKING; TOBACCO SMOKE POLLUTION; VENTRICULAR PRESSURE;

RATTUS;

EID: 84863328182     PISSN: 08958378     EISSN: 10917691     Source Type: Journal    
DOI: 10.3109/08958378.2012.688885     Document Type: Article

References (39)

1. Andrae J, Gallini R, Betsholtz C. 2008. Role of platelet-derived growth factors in physiology and medicine. Genes Dev 22:1276-1312. (Pubitemid 351717519)
2. Arcot SS, Lipke DW, Gillespie MN, Olson JW. 1993. Alterations of growth factor transcripts in rat lungs during development of monocrotaline-induced pulmonary hypertension. Biochem Pharmacol 46:1086-1091. (Pubitemid 23280552)
3. Barst RJ. 2005. PDGF signaling in pulmonary arterial hypertension. J Clin Invest 115:2691-2694. (Pubitemid 41434394)
4. Basciani S, Mariani S, Arizzi M, Brama M, Ricci A, Betsholtz C, Bondjers C, Ricci G, Catizone A, Galdieri M, Spera G, Gnessi L. 2004. Expression of platelet-derived growth factor (PDGF) in the epididymis and analysis of the epididymal development in PDGF-A, PDGF-B, and PDGF receptor ? deficient mice. Biol Reprod 70:168-177. (Pubitemid 38063564)
5. Betsholtz C, Lindblom P, Bjarnegard M, Enge M, Gerhardt H, Lindahl P. 2004. Role of platelet-derived growth factor in mesangium development and vasculopathies: lessons from platelet-derived growth factor and platelet-derived growth factor receptor mutations in mice. Curr Opin Nephrol Hypertens 13:45-52. (Pubitemid 39069898)
6. Bonner JC. 2004. Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev 15:255-273. (Pubitemid 38781050)
7. Cao Y, Cao R, Hedlund EM. 2008. R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways. J Mol Med 86:785-789.
8. Carraway MS, Ghio AJ, Suliman HB, Carter JD, Whorton AR, Piantadosi CA. 2002. Carbon monoxide promotes hypoxic pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 282:L693-L702. (Pubitemid 34665584)
9. Carty CS, Huribal M, Marsan BU, Ricotta JJ, Dryjski M. 1997. Nicotine and its metabolite cotinine are mitogenic for human vascular smooth muscle cells. J Vasc Surg 25:682-688. (Pubitemid 27190932)
10. De Cunto G, Cardini S, Cirino G, Geppetti P, Lungarella G, Lucattelli M. 2011. Pulmonary hypertension in smoking mice over-expressing protease-activated receptor-2. Eur Respir J 37:823-834.
11. Farooqi AA, Waseem S, Riaz AM, Dilawar BA, Mukhtar S, Minhaj S, Waseem MS, Daniel S, Malik BA, Nawaz A, Bhatti S. 2011. PDGF: the nuts and bolts of signalling toolbox. Tumour Biol 32:1057-1070.
12. Garat CV, Crossno JT Jr, Sullivan TM, Reusch JE, Klemm DJ. 2010. Thiazolidinediones prevent PDGF-BB-induced CREB depletion in pulmonary artery smooth muscle cells by preventing upregulation of casein kinase 2 ?' catalytic subunit. J Cardiovasc Pharmacol 55:469-480.
13. Ghofrani HA, Seeger W, Grimminger F. 2005. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 353:1412-1413. (Pubitemid 41362714)
14. Grimminger F, Schermuly RT. 2010. PDGF receptor and its antagonists: role in treatment of PAH. Adv Exp Med Biol 661:435-446.
15. Han SX, He GM, Wang T, Chen L, Ning YY, Luo F, An J, Yang T, Dong JJ, Liao ZL, Xu D, Wen FQ. 2010. Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2. Toxicol Appl Pharmacol 245:100-107.
16. Heldin CH, Westermark B. 1999. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79:1283-1316. (Pubitemid 29473317)
17. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, Christman BW, Weir EK, Eickelberg O., Voelkel NF, and Rabinovitch M. 2004. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 43:13S-24S. (Pubitemid 38759713)
18. Jankov RP, Kantores C, Belcastro R, Yi S, Ridsdale RA, Post M, Tanswell AK. 2005. A role for platelet-derived growth factor ?-receptor in a newborn rat model of endothelin-mediated pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 288:L1162-L1170. (Pubitemid 40695443)
19. Jawien A, Bowen-Pope DF, Lindner V, Schwartz SM, Clowes AW. 1992. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 89:507-511.
20. Jeffery TK, Wanstall JC. 2001. Pulmonary vascular remodeling: a target for therapeutic intervention in pulmonary hypertension. Pharmacol Ther 92:1-20. (Pubitemid 34032020)
21. Lahm T, Crisostomo PR, Markel TA, Wang M, Lillemoe KD, Meldrum DR. 2007. The critical role of vascular endothelial growth factor in pulmonary vascular remodeling after lung injury. Shock 28:4-14. (Pubitemid 46956456)
22. Millette E, Rauch BH, Kenagy RD, Daum G, and Clowes AW. 2006. Platelet-derived growth factor-BB transactivates the fibroblast growth factor receptor to induce proliferation in human smooth muscle cells. Trends Cardiovasc Med 16:25-28. (Pubitemid 43012038)
23. Oltmanns U, Chung KF, Walters M, John M, Mitchell JA. 2005. Cigarette smoke induces IL-8, but inhibits eotaxin and RANTES release from airway smooth muscle. Respir Res 6:74.
24. Ou XM, Wen FQ, Uhal BD, Feng YL, Huang XY, Wang T, Wang K, Liu DS, Wang X, Chen L. 2009. Simvastatin attenuates experimental small airway remodelling in rats. Respirology 14:734-745.
25. Overbeek MJ, Boonstra A, Voskuyl AE, Vonk MC, Vonk-Noordegraaf A, van Berkel MP, Mooi WJ, Dijkmans BA, Hondema LS, Smit EF, Grünberg K. 2011. Platelet-derived growth factor receptor-ß and epidermal growth factor receptor in pulmonary vasculature of systemic sclerosisassociated pulmonary arterial hypertension versus idiopathic pulmonary arterial hypertension and pulmonary veno-occlusive disease: a case-control study. Arthritis Res Ther 13:R61.
26. Patterson KC, Weissmann A, Ahmadi T, Farber HW. 2006. Imatinib mesylate in the treatment of refractory idiopathic pulmonary arterial hypertension. Ann Intern Med 145:152-153. (Pubitemid 46780594)
27. Perros F, Montani D, Dorfmüller P, Durand-Gasselin I, Tcherakian C, Le Pavec J, Mazmanian M, Fadel E, Mussot S, Mercier O, Hervé P, Emilie D, Eddahibi S, Simonneau G, Souza R, Humbert M. 2008. Platelet-derived growth factor expression and function in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 178:81-88. (Pubitemid 351919196)
28. Pestana IA, Vazquez-Padron RI, Aitouche A, Pham SM. 2005. Nicotinic and PDGF-receptor function are essential for nicotine-stimulated mitogenesis in human vascular smooth muscle cells. J Cell Biochem 96:986-995. (Pubitemid 41693470)
29. Pietra GG, Capron F, Stewart S, Leone O, Humbert M, Robbins IM, Reid LM, and Tuder RM. 2004. Pathologic assessment of vasculopathies in pulmonary hypertension. J Am Coll Cardiol 43:25S-32S. (Pubitemid 38759714)
30. Rabinovitch M. 2008. Molecular pathogenesis of pulmonary arterial hypertension. J Clin Invest 118:2372-2379. (Pubitemid 351949764)
31. Sakao S, Tatsumi K, Voelkel NF. 2010. Reversible or irreversible remodeling in pulmonary arterial hypertension. Am J Respir Cell Mol Biol 43:629-634.
32. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, Grimminger F. 2005. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115:2811-2821. (Pubitemid 41434408)
33. Souza R, Sitbon O, Parent F, Simonneau G, Humbert M. 2006. Long term imatinib treatment in pulmonary arterial hypertension. Thorax 61:736. (Pubitemid 44211786)
34. Uutela M, Laurén J, Bergsten E, Li X, Horelli-Kuitunen N, Eriksson U, Alitalo K. 2001. Chromosomal location, exon structure, and vascular expression patterns of the human PDGFC and PDGFD genes. Circulation 103:2242-2247. (Pubitemid 32433712)
35. Villablanca AC. 1998. Nicotine stimulates DNA synthesis and proliferation in vascular endothelial cells in vitro. J Appl Physiol 84:2089-2098. (Pubitemid 28255971)
36. Voelkel NF, Vandivier RW, Tuder RM. 2006. Vascular endothelial growth factor in the lung. Am J Physiol Lung Cell Mol Physiol 290:L209-L221.
37. Wright JL, Levy RD, Churg A. 2005. Pulmonary hypertension in chronic obstructive pulmonary disease: current theories of pathogenesis and their implications for treatment. Thorax 60:605-609. (Pubitemid 40966216)
38. Yamabe H, Osawa H, Kaizuka M, Tsunoda S, Shirato K, Tateyama F, Okumura K. 2000. Platelet-derived growth factor, basic fibroblast growth factor, and interferon gamma increase type IV collagen production in human fetal mesangial cells via a transforming growth factor-?-dependent mechanism. Nephrol Dial Transplant 15:872-876. (Pubitemid 30312010)
39. Yi ES, Lee H, Yin S, Piguet P, Sarosi I, Kaufmann S, Tarpley J, Wang NS, Ulich TR. 1996. Platelet-derived growth factor causes pulmonary cell proliferation and collagen deposition in vivo. Am J Pathol 149:539-548. (Pubitemid 26256342)